Monitor for potential commercial partnerships or validation opportunities following this high-profile academic presentation, though no immediate financial impact is expected.
Price Chart
Executive Summary
bioAffinity Technologies announced that its CyPath® Lung test will be featured at the Cleveland Clinic's 'Advances in Early Lung Cancer Detection' symposium on April 16, 2026, with Chief Medical Officer Dr. Gordon Downie participating in a panel discussion. This marks the company's seventh consecutive invitation to the event.
Key Facts
- CyPath® Lung test will be featured at Cleveland Clinic symposium on April 16, 2026
- Chief Medical Officer Dr. Gordon Downie will participate in a panel on lung nodule management
- This is the seventh consecutive year the company has been invited to present at this symposium
- The test uses sputum-based analysis with flow cytometry and AI to detect lung cancer
Financial Impact
No immediate financial impact disclosed
Risk Factors
- Small market cap ($2M) makes the stock highly speculative
- No revenue or commercial adoption metrics disclosed in filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-015445 |
| Exhibit: ex99-1.htm | 0001493152-26-015445 |
| Document: 0001493152-26-015445-index-headers.html | 0001493152-26-015445 |
| Document: 0001493152-26-015445-index.html | 0001493152-26-015445 |
| Document: 0001493152-26-015445.txt | 0001493152-26-015445 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jun 2, 2026 20w ago | 8-K | $0.2950 $0.1300 | ▼ −55.93% | ▼ −54.37% | — |
May 27, 2026 21w ago | 8-K | $0.2950 $0.2950 | · 0.00% | ▲ +1.90% | — |
May 13, 2026 23w ago | EFFECT | $0.2950 $0.2950 | · 0.00% | ▲ +0.61% | — |
May 12, 2026 23w ago | 8-K | $0.2950 $0.2950 | · 0.00% | ▲ +1.73% | — |
May 8, 2026 24w ago | 8-K | $0.2950 $0.2950 | · 0.00% | ▼ −0.02% | — |
Apr 14, 2026 27w ago | 8-K | $0.2950 $0.2950 | · 0.00% | ▼ −6.30% | — |
Apr 7, 2026 28w ago | 8-K | $0.2950 $0.2950 | · 0.00% | ▼ −9.78% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers